Aeolus Pharmaceuticals, Inc.
AOLS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.21K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $15,209.00 |
|---|---|
| Enterprise Value | $-387,791.00 |
| Earnings per Share | $-0.04 |
| Beta | -5.55 |
| Outstanding Shares | 152,086,000 |
Return
| Return on Equity | -1977.78% |
|---|---|
| Return on Assets | -515.62% |
| Return on Invested Capital | -1977.78% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | -0.03 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.5 |
| Enterprise Value to EBIT | 0.09 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Aeolus Pharmaceuticals, Inc.
4 employees
CEO: Christopher Stanley
Aeolus Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the development of innovative therapeutic compounds. Operating within the United States, the company's research pipeline addresses a diverse range of critical medic...